Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma.

Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma.
复制标题

DOI:
10.1038/sj.bjc.6602806
复制
发表时间:
2005-10-17
影响因子:
8.8
通讯作者:
--
中科院分区:
医学1区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

Cyclooxygenase 2 (Cox-2) is upregulated in colorectal adenomas and carcinomas. Polymorphisms in the Cox-2 gene may influence its function and/or its expression and may modify the protective effect of nonsteroidal anti-inflammatory drugs (NSAIDs), thereby impacting individuals' risk of developing colorectal cancer and response to prevention/intervention strategies. In a nested case–control study, four polymorphisms in the Cox-2 gene (two in the promoter, −663 insertion/deletion, GT/(GT) and −798 A/G; one in intron 5-5229, T/G; one in 3′untranslated region (UTR)-8494, T/C) were genotyped in 726 cases of colorectal adenomas and 729 age- and gender-matched controls in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial. There was no significant association between the Cox-2 polymorphisms and adenoma development in the overall population. However, in males, the relatively rare heterozygous genotype GT/(GT) at −663 in the promoter and the variant homozygous genotype G/G at intron 5-5229 appeared to have inverse associations (odds ratio (OR)=0.59, confidence interval (CI): 0.34–1.02 and OR=0.48, CI: 0.24–0.99, respectively), whereas the heterozygous genotype T/C at 3′UTR-8494 had a positive association (OR=1.31, CI: 1.01–1.71) with adenoma development. Furthermore, the haplotype carrying the risk-conferring 3′UTR-8494 variant was associated with a 35% increase in the odds for adenoma incidence in males (OR=1.35, CI: 1.07–1.70), but the one with a risk allele at 3′UTR-8494 and a protective allele at intron 5-5229 had no effect on adenoma development (OR=0.85, CI: 0.66–1.09). Gender-related differences in adenoma risk were also noted with tobacco usage and protective effects of NSAIDs. Our analysis underscores the significance of the overall allelic architecture of Cox-2 as an important determinant for risk assessment.
DOI: 10.1056/nejm199509073331001
发表时间: 1995-09-07
影响因子: 158.5
作者:
GIOVANNUCCI, E;EGAN, KM;SPEIZER, FE
通讯作者: SPEIZER, FE
DOI: 10.1016/s0197-2456(00)00097-0
发表时间: 2000-12-01
期刊: CONTROLLED CLINICAL TRIALS
影响因子: --
作者:
Gohagan, JK;Prorok, PC;Kramer, BS
通讯作者: Kramer, BS
DOI: 10.1074/jbc.275.16.11750
发表时间: 2000-04-21
影响因子: 4.8
作者:
Dixon, DA;Kaplan, CD;Prescott, SM
通讯作者: Prescott, SM
DOI: 10.1111/j.1572-0241.2001.03638.x
发表时间: 2001-03-01
影响因子: 9.8
作者:
McCashland, TM;Brand, R;de Garmo, P
通讯作者: de Garmo, P
DOI: 10.1016/s0014-5793(01)02422-x
发表时间: 2001-05-11
期刊: FEBS LETTERS
影响因子: 3.5
作者:
Mestre, JR;Rivadeneira, DE;Daly, JM
通讯作者: Daly, JM